×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 16: NDA Submission, FDA Review, and Action on Applications
Session Chair(s)
Elliott Berger, PhD, MS
President
ETB Regualtory Consulting, United States
- Electronic Submissions
- FDA Review of Applications and Actions on Applications
- Amendments to an Unapproved Application
- Reasons Applications are not Approved PDUFA
Have an account?